Translational Development Acquisition Corp. (TDAC) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$10.85

From 52W high−0.83%

Volume7317.00

Market cap$208.73M

P/E (TTM)42.0x

P/S (TTM)—

Div yield—

Key dataOct 19, 2026

Open

$10.85

From 52W high

−0.83%

Volume

7317.00

Market cap

$208.73M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−159.1x

P/E (TTM)

42.0x

RSI (14)

53.2

MomentumView details →

1D Return

−0.16%

YTD Return

+3.43%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

42.0x

EV/EBITDA

−159.1x

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

1.4x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

3.70%

ROA (TTM)

3.52%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

−39.74%

FCF YoY

—

Revenue CAGR 3Y

−100.00%

EPS CAGR 3Y

+2383.95%

EBITDA YoY

−72.34%

MomentumView details →

1D Return

−0.16%

YTD Return

+3.43%

1Y Return

+4.43%

RSI (14)

53.2

vs 50D SMA

+0.01%

vs 200D SMA

+1.55%

Capital & dividendView details →

Debt/Equity

0.01x

Current Ratio

0.06x

Quick Ratio

0.06x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

$0.04

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

5.54M

Op. CF (TTM)

−849378.00

Latest newsMore news →

ProLogium and Translational Development Acquisition Corp. announced a $50 million committed primary capital investment from existing ProLogium shareholders to support their business combination that will make ProLogium a publicly listed company.84d ago

Translational Development Acquisition Company announced that ProLogium has filed an F-4 with the SEC as part of their planned de-SPAC merger.106d ago

Similar companies

Abony Acquisition Corp. I UnitsAACOU Market Technology Acquisition Corp.MTAKU Vendome Acquisition Corporation I UnitVNMEU BOA Acquisition Corp. II RightsTHEOR Boa Acquisition Corp. IiTHEO Harvard Ave Acquisition Corporation Class A Ordinary ShareHAVA Find similar companies →

Latest newsMore news →

ProLogium and Translational Development Acquisition Corp. announced a $50 million committed primary capital investment from existing ProLogium shareholders to support their business combination that will make ProLogium a publicly listed company.84d ago Translational Development Acquisition Company announced that ProLogium has filed an F-4 with the SEC as part of their planned de-SPAC merger.106d ago